Showing results (1601-1610 of 4,426) with videos related to
Sort By:
Pageof 443
Cancer Cell International|November 26, 2021
Characterization of a novel glucocorticoid-resistant human B-cell acute lymphoblastic leukemia cell line, with AMPK, mTOR and fatty acid synthesis pathway inhibitionYuanyuan Li, Chuan Zuo, Ling GuCancer Cell International|January 8, 2022
Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axisPeng Xu, Kang Hu, Ping Zhang, et al.Cancer Cell International|January 16, 2022
SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinomaXin Zhang, Hongwei Zhang, Zhibin Liao, et al.Cancer Cell International|January 16, 2022
Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genesJihua Yang, XiaoHong Wei, Fang Hu, et al.Cancer Cell International|January 16, 2022
MiR-937-3p promotes metastasis and angiogenesis and is activated by MYC in lung adenocarcinomaZijian Ma, Ganyi Chen, Yiqian Chen, et al.Cancer Cell International|January 19, 2022
4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosisWei Li, Bai-Sheng Huang, Yuan-Yuan Xiong, et al.Cancer Cell International|November 13, 2021
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world studyYa-Nan Jin, Meng-Yun Qiang, Meng-Meng Liu, et al.Cancer Cell International|November 5, 2021
CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3Mei Mei, Yingjun Wang, Wenting Song, et al.Cancer Cell International|November 5, 2021
Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune responseHan Zhang, Yijun Wu, Hao Li, et al.Cancer Cell International|December 13, 2021
Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancerJunhao Zhou, Hu Tian, Xi Zhi, et al.Pageof 443